Acute Porphyria Drug Database

Monograph

R01AX03 - Ipratropium Bromide
Not porphyrinogenic
NP

Rationale
Hydrophilic substance, insignificant systemic exposure.
Chemical description
Ipratropium bromide, anticholinergic used in treatment (nasal spray 21 - 42 µg/dose) of rhinitis. Plasma levels below detection limit, only 3 - 6 % of the dose recovered in urine.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes R01A / R01AX or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Ipratropium · Ipratropium bromide 21micrograms/dose nasal spray · Rinaspray · Rinaspray 21micrograms/dose nasal spray
Denmark
Atrovent · Atrovent Nasal · Iprazap · Lomuspray
Norway
Atrovent Nasal · Atrovent Nasal orifarm · Ipratropium Bromide west-ward · Lomuspray · Pms-Ipratropium
Iceland
Lomuspray
Finland
Atrovent Nasal · Rinivent
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙